Molecular epidemiology of group B streptococcal infections

Folia Microbiologica

Volumn 49, Issue 4, 2004, Pages 387-397

  Tkacikova L ' ^a,b   Mikula, I ^a,b   Dmitriev, A ^c  

^a UNIVERSITY OF VETERINARY MEDICINE   (Slovakia)

^b INSTITUTE OF NEUROIMMUNOLOGY   (Slovakia)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS;

ANIMAL; GENETICS; HUMAN; POLYMERASE CHAIN REACTION; RANDOM AMPLIFIED POLYMORPHIC DNA; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; RIBOTYPING; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; VIRULENCE;

ANIMALS; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; RIBOTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; VIRULENCE;

EID: 5444224980     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03354665     Document Type: Review

References (100)

1. Backman A., Lantz P., Radstrom P., Olcen P.: Evaluation of an extended diagnostic PCR assay for detection and verification of the common causes of bacterial meningitis in CSF and other biological samples. Mol.Cell.Probes13, 49–60 (1999).
2. Baker C.J.: Group B streptococcal infections. Clin.Perinatol.24, 59–70 (1997).
3. Baker C.J., Barett F.F.: Group B streptococcal infections in infants. J.Am.Med.Assoc.230, 1158–1160 (1974).
4. Benson J.A., Ferrieri P.: Rapid pulsed-field gel electrophoresis method for group B streptococcus isolates. J.Clin.Microb.39, 3006–3008 (2001).
5. Benson K.D., Luchansky J.B., Elliott J.A., Degnan A.J., Willenberg H.J., Thornbery J.M., Kay H.H.: Pulsed-field finger-printing of vaginal group B streptococcus in pregnancy. Obstet.Gynecol.100, 545–551 (2002).
6. Bevanger L.: Ibc proteins as serotype markers of group B streptococci. Acta Pathol.Microbiol.Immunol.Scand.Sect.B 231–234 (1991).
7. Bevanger L., Brakstad O.G., Maeland J.A., Kvam A.I., Iversen G., Lyng R.V.: Aberrations in expression of the β antigen of Streptococcus agalactiae. Adv.Exp.Med.Biol.418, 999–1001 (1997).
8. Bingen E., Denamur E., Lambert-Zechovsky N., Aujard Y., Brahimi N., Geslin P., Elion J.: Analysis of DNA restriction fragment polymorphism extends the evidence for breast milk transmission in Streptococcus agalactiae late-onset neonatal infection. J.Infect.Dis.165, 569–573 (1992).
9. Blumberg H.M., Stephens D.S., Licitra C., Pigott N., Facklam R., Swaminathan B., Wachsmuth I.K.: Molecular epidemiology of group B streptococcal infections: use of restriction endonuclease analysis of chromosomal DNA and DNA restriction fragment length polymorphism of ribosomal RNA genes (ribotyping). J.Infect.Dis.166, 574–579 (1992).
10. Chaffin D.O., Beres S.B., Yim H.H., Rubens C.E.: The serotype of type Ia and III group B streptococci is determined by the polymerase gene within the polycistronic capsule operon. J.Bacteriol.182, 4466–4477 (2000).
11. Chatellier S., Huet H., Kenzi S., Rosenau A., Geslin P., Quentin R.: Genetic diversity of rRNA operons of unrelated Streptococcus agalactiae strains isolated from cerebrospinal fluid of neonates suffering from meningitis. J.Clin.Microbiol.34, 2741–2747 (1996).
12. Chatellier S., Ramanantsoa C., Harriau P., Rolland K., Rosenau A., Quentin R.: Characterization of Streptococcus agalactiae strains by randomly amplified polymorphic DNA analysis. J.Clin.Microbiol.35, 2573–2579 (1997).
13. Chmouryguina I.I., Suvorov A.N., Ferrieri P., Cleary P.P.: Conservation of C5a peptidase genes in group A and B streptococci. Infect.Immun.64, 2387–2390 (1996).
14. Davin-Regli A., Abed Y., Charrel R.N., Bollet C., de Micco P.: Variations in DNA concentrations significantly affects the reproducibility of RAPD fingerprint patterns. Res.Microbiol.146, 561–568 (1995).
15. Denning D.V., Bacer C.J., Troup N.J., Tompkins L.S.: Restriction endonucleases analysis of human and bovine group B streptococcus for epidemiologic study. J.Clin.Microbiol.27, 1352–1356 (1989).
16. Dinger J., Muller D., Pargac N., Schwarze R.: Breast milk transmission of group B streptococcal infection. Pediatr.Infect.Dis.J.21, 567–568 (2002).
17. Dmitriev A., Tkačiková L’., Suvorov A., Kantiková M., Mikula I., Totolyan A.: Comparative genetic study of group B streptococcal strains of human and bovine origin. Folia Microbiol.44, 449–453 (1999).
18. Dmitriev A., Totolian A., Tkáčiková L’., Mikula I.: Features of the genome structure of group B streptococci of bovine origin. Folia Veter.45, 57–63 (2001).
19. Dmitriev A., Hu Y.Y., Shen A.D., Suvorov A., Yang Y.H.: Chromosomal analysis of group B streptococcal clinical strains; bac gene positive strains are genetically homogenous. FEMS Microb.Lett.208, 93–98 (2002a).
20. Dmitriev A., Shakleina E., Tkáčiková L’., Mikula I., Totolian A.: Genetic heterogeneity of the pathogenic potentials of human and bovine group B streptococci. Folia Microbiol.47, 291–295 (2002b).
21. Dmitriev A., Yang M., Shakleina E., Tkáčiková L’., Suvorov A., Mikula I., Yang Y.H.: The presence of insertion elements IS861 and IS1548 in group B streptococci. Folia Microbiol.48, 105–110 (2003).
22. Dmitriev A., Suvorov A., Shen A.D., Yang Y.H.: Clinical diagnosis of group B streptococci by scpB gene based PCR. Indian J.Med.Res.119 (Suppl.), 230–233 (2004a).
23. Dmitriev A., Shen A., Shen X., Yang Y.H.: ISSa4 based differentiation of Streptococcus agalactiae strains and identification of multiple target sites for ISSa4 insertions. J.Bacteriol.186, 1106–1109 (2004b).
24. Elliot J.A., Farmer K.D., Facklam R.R.: Sudden increase in isolation of group B streptococci, serotype V, is not due to emergence of a new pulsed-field gel electrophoresis type. J.Clin.Microbiol.36, 2115–2116 (1998).
25. Ellis S., Kotiw M., Garland S.M.: Restriction endonuclease analysis of group B streptococcal isolates from two distinct geographical regions. J.Hosp.Infect.33, 279–287 (1996).
26. Fasola E., Livdahl C., Ferrieri P.: Molecular analysis of multiple isolates of the major serotypes of group B streptococci. J.Clin. Microbiol.31, 2616–2620 (1993).
27. Ferrieri P., Cho D.S., Livdahl C., Rubens C.E., Flores A.E.: DNA restriction profiles of nontypable group B streptococcal clinical isolates. Adv.Exp.Med.Biol.418, 343–346 (1997).
28. Flores A.E., Ferrieri P.: Molecular species of R-protein antigens produced by clinical isolates of group B streptococci. J.Clin.Microbiol.27, 1050–1057 (1989).
29. Franken C., Haase G., Brandt C.: Horizontal gene transfer and host specificity of β-hemolytic streptococci: the role of a putative composite transposon containing scpB and lmb. Mol.Microbiol.41, 925–935 (2001).
30. Fuchs P.C., Christy C., Jones R.N.: Multiple-inocula (replicator) CAMP test for presumptive identification of group B streptococci. J.Clin.Microbiol.7, 232–233 (1978).
31. Gase K., Ozegowski J., Malke H.: The Streptococcus agalactiae hylB gene encoding hyaluronate lyase: completion of the sequence and expression analysis. Biochim.Biophys.Acta1398, 86–98 (1998).
32. Gase K., Ferretti J.J., Primeaux C., McShan W.M.: Identification, cloning, and expression of the CAMP factor gene (cfa) of group A streptococci. Infect.Immun.67, 4725–4731 (1999).
33. Glaser P., Rusniok C., Buchrieser C., Chevalier F., Frangeul L., Msadek T., Zouine M., Couve E., Lalioui L., Poyart C., Trieu-Cuot P., Kunst F.: Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease. Mol.Microbiol.45, 1499–1513 (2002).
34. Gordillo M.E., Singh K.V., Baker C.J., Murray B.E.: Typing of group B streptococci: comparison of pulsed-field gel electrophoresis and conventional electrophoresis. J.Clin.Microbiol.31, 1430–1434 (1993).
35. Granlund M., Oberg L., Sellin M., Norgren M.: Identification of a novel insertion element, IS1548, in group B streptococci, predominantly in strains causing endocarditis. J.Infect.Dis.177, 967–976 (1998).
36. Greisen K., Loeffelholz M., Purohit A., Leong D.: PCR primers and probes for the 16S rRNA gene of most species of pathogenic bacteria, including bacteria found in cerebrospinal fluid. J.Clin.Microbiol.32, 335–351 (1994).
37. Gurtler V., Stanisich V.A.: New approaches to typing and identification of bacteria using the 16S-23S rDNA spacer region. Microbiology142, 3–16 (1996).
38. Hall L.M., Duke B., Urwin G.: An approach to the identification of the pathogens of bacterial meningitis by the polymerase chain reaction. Eur.J.Clin.Microbiol.Infect.Dis.14, 1090–1094 (1995).
39. Harrison L.H., Elliott J.A., Dwyer D.M., Libonati J.P., Ferrieri P., Billmann L., Schuchat A.: Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation: Maryland Emerging Infections Program. J.Infect.Dis.177, 998–1002 (1998).
40. Hassan A., Abdulmawjood A., Yildirim A.O., Fink K., Lammler C., Schlenstedt R.: Identification of streptococci isolated from various sources by determination of cfb gene and other CAMP-factor genes. Can.J.Microbiol.46, 946–951 (2000).
41. Haug R.H., Hoiby E.A., Lermark G.: Serotyping and bacteriophage typing of group B streptococci. Nat.Inst.Publ.Health Ann. (Norway)6, 119–123 (1983).
42. Hauge M., Jespersgaard C., Poulsen K., Kilian M.: Population structure of Streptococcus agalactiae reveals an association between specific evolutionary lineages and putative virulence factors but not disease. Infect.Immun.64, 919–925 (1996).
43. Heden L.O., Frithz E., Lindahl G.: Molecular characterization of an IgA receptor from group B streptococci: sequence of the gene, identification of a proline-rich region with unique structure and isolation of N-terminal fragments with IgA-binding capacity. Eur.J.Immunol.21, 1481–1490 (1991).
44. Horaud T., de Cespedes G., Trieu-Cuot P.: Chromosomal gentamicin resistance transposon Tn3706 in Streptococcus agalactiae B128. Antimicrob.Agents Chemother.40, 1085–1090 (1996).
45. Huet H., Martin C., Geslin P., Grimont F., Quentin R.: Ribotyping of Streptococcus agalactiae strains isolated from vaginas of asymptomatic women. Res.Microbiol.144, 457–465 (1993).
46. Hynes W.L., Ferretti J.J.: Sequence analysis and expression in Escherichia coli of the hyaluronidase gene of Streptococcus pyogenes. Infect.Immun.57, 533–539 (1989).
47. Jensen N.E., Aarestrup F.M.: Epidemiological aspects of group B streptococci of bovine and human origin. Epidemiol.Infectol.117, 417–422 (1996).
48. Jerlstrom P.J., Chhatwal G.S., Timmis K.N.: The IgA binding β antigen of the c protein complex of group B streptococci: sequence determination of its gene and detection of two binding regions. Mol.Microbiol.5, 843–849 (1991).
49. Jones A.L., Knoll K.M., Rubens C.E.: Identification of Streptococcus agalactiae virulence genes in the neonatal rat sepsis model using signature-tagged mutagenesis. Mol.Microbiol.37, 1444–1455 (2000).
50. Kalliola S., Vuopio-Varkila J., Takala A., Eskola J.: Neonatal group B streptococcal disease in Finland: a ten-year nation-wide study. Pediatr.Infect.Dis.J.18, 806–810 (1999).
51. Keefe G.P.: Streptococcus agalactiae mastitis: a review. Can.Vet.J.38, 429–437 (1997).
52. Kong F., Gowan S., Martin D., James G., Gilbert G.L.: Molecular profiles of group B streptococcal surface protein antigen genes: relationship to molecular serotypes. J.Clin.Microbiol.40, 620–626 (2002).
53. Lachenauer C.S., Kasper D.L., Shimada J., Ichiman Y., Ohtsuka H., Kaku M., Paoletti L.C., Ferrieri P., Madoff L.C.: Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. J.Infect.Dis.179, 1030–1033 (1999).
54. Lachenauer C.S., Creti R., Michel J.L., Madoff L.C.: Mosaicism in the α-like protein genes of group B streptococci. Proc.Nat. Acad.Sci.USA97, 9630–9635 (2000).
55. Lancefield R.C.: A serological differentiation of specific types of bovine hemolytic streptococci (group B). J.Exp.Med.59, 441–458 (1934).
56. Larsson C., Stalhammar-Carlemalm M., Lindahl G.: Experimental vaccination against group B streptococcus, as encapsulated bacterium, with highly purified preparations of cell surface proteins Rib and α. Infect.Immun.64, 3518–3523 (1996).
57. Limansky A.S, Guardati M.C., Sutich E.G., Toresani I.E., Bogado I.E., Joannas G.M., Viale A.M.: Characterization of clinical isolates of Streptococcus agalactiae by random amplified polymorphic DNA using degenerate oligonucleotides. Medicina (Buenos Aires)55, 681–684 (1995).
58. Limansky A.S., Sutich E.G., Guardati M.C., Toresani I.E., Viale A.M.: Genomic diversity among Streptococcus agalactiae isolates detected by a degenerate oligonucleotide-primed amplification assay. J.Infect.Dis.177, 1308–1313 (1998).
59. Madoff L.C., Michel J.L., Gong E.W., Rodewald A.K., Kasper D.L.: Protection of neonatal mice from group B streptococcal infection by maternal immunization with β-C protein. Infect.Immun.60, 4989–4994 (1992).
60. Mahillon J., Chandler M.: Insertion sequences. Microbiol.Mol.Biol.Rev.62, 725–774 (1998).
61. Martinez G., Harel J., Higgins R., Lacouture S., Daignault D., Gottschalk M.: Characterization of Streptococcus agalactiae isolates of bovine and human origin by randomly amplified polymorphic DNA analysis. J.Clin.Microbiol.38, 71–78 (2000).
62. Martinez G., Harel J., Gottschalk M.: Specific detection by PCR of Streptococcus agalactiae in milk. Can.J.Vet.Res.65, 68–72 (2001).
63. Melchers W.J., Bakkers J.M., Toonen M., van Kuppeveld F.J., Trijbels M., Hoogkamp-Korstanje J.A.: Genetic analysis of Streptococcus agalactiae strains isolated from neonates and their mothers. FEMS Immunol.Med.Microbiol.36, 111–113 (2003).
64. Michel J.L., Madoff L.C., Oloson K., Kling D.E., Kasper D.L., Ausubel F.M.: Large, identical tandem repeating units in the C protein α antigen gene, bca, of group B streptococci. Proc.Nat.Acad.Sci.USA89, 10060–10064 (1993).
65. Mileham A.J.: Identification of microorganisms using random primed PCR. Mol.Biotechnol.8, 139–145 (1997).
66. Nagano Y., Nagano N., Takahashi S., Murono K., Fujita K., Taguchi F., Okuwaki Y.: Restriction endonuclease digest patterns of chromosomal DNA from group B β-hemolytic streptococci. J.Med.Microbiol.35, 297–303 (1991).
67. Nizet V., Ferrieri P., Rubens C.: Molecular pathogenesis of group B streptococcal disease in newborns, pp. 80–221 in Streptococcal Infections. Clinical Aspects, Microbiology and Molecular Pathogenesis (D.L. Stevens, E.L. Kaplan, Eds.). Oxford University Press, New York 2000.
68. Oguro H.: A study of group B streptococcus with special reference to the relationship between serological type and virulence. J.Jap. Assoc.Infect.Dis.58, 376–384 (1983).
69. Olcen P., Lantz P.G., Backman A., Radstrom P.: Rapid diagnosis of bacterial meningitis by a seminested PCR strategy. Scand.J. Infect.Dis.27, 537–539 (1995).
70. Pattison I.H., Matthews P.R.J., Howell D.G.: The type classification of group B streptococci, with special reference to bovine strains apparently lacking in type polysaccharide. J.Pathol.Bacteriol.69, 51–60 (1955).
71. Phuektes P., Mansell P.D., Browning G.F.: Multiplex polymerase chain reaction assay for simultaneous detection of Staphylococcus aureus and streptococcal causes of bovine mastitis. J.Dairy Sci.84, 1140–1148 (2001).
72. Quentin R., Huet H., Wang F.S., Geslin P., Goudeau A., Selander R.K.: Characterization of Streptococcus agalactiae strains by multilocus enzyme genotype and serotype: identification of multiple virulent clone families that cause invasive neonatal diseases. J.Clin.Microbiol.33, 2576–2581 (1995).
73. Radstrom P., Backman A., Qian N., Kragsbjerg P., Pahlson C., Olcen P.: Detection of bacterial DNA in cerebrospinal fluid by an assay for simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and streptococci using a seminested PCR strategy. J.Clin.Microbiol.32, 2738–2744 (1994).
74. Regan J.A., Klebanoff M.A., Nugent R.P., Eschenbach D.A., Blackwelder W.C., Lou Y., Gibbs R.S., Rettig P.J., Martin D.H., Edelman R.: Colonization with group B streptococci in pregnancy adverse outcome. VIP study group. Am.J.Obstet. Gynecol.174, 1354–1360 (1996).
75. Riffon R., Sayasith K., Khalil H., Dubreuil P., Drolet M., Lagace J.: Development of a rapid and sensitive test for identification of major pathogens in bovine mastitis by PCR. J.Clin.Microbiol.39, 2584–2589 (2001).
76. Rolland K., Marois C., Siquier V., Cattier B., Quentin R.: Genetic features of Streptococcus agalactiae strains causing severe neonatal infections, as revealed by pulsed-field gel electrophoresis and hylB gene analysis. J.Clin.Microbiol.37, 1892–1898 (1999).
77. Rubens C.E., Wessel M.R., Heggen L.M., Kasper D.L.: Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence. Proc.Nat.Acad.Sci.USA84, 7208–7212 (1987).
78. Rubens C.E., Heggen L.M., Kuypers J.M.: IS861, a group B streptococcal insertion sequence related to IS150 and IS3 of Escherichia coli. J.Bacteriol.171, 5531–5535 (1989).
79. Russel H., Norcross N.L., Kahn D.E.: Isolation and characterization of Streptococcus agalactiae bacteriophage. J.Gen.Virol.5, 315–317 (1969).
80. Schalen C.: Prevalence of IgA receptors in clinical isolates of Streptococcus pyogenes and Streptococcus agalactiae: serological distinction between the receptors by blocking antibodies. FEMS Immunol.Med.Microbiol.7, 39–46 (1993).
81. Schnitzler N., Haase G., Podbielski A., Kaufhold A., Lammler C., Lutticken R.: Human isolates of large colony-forming β hemolytic group G streptococci form a distinct clade upon 16S rRNA gene analysis. Adv.Exp.Med.Biol.418, 363–365 (1997).
82. Sechter I., Mestre F., Hansen D.S.: Twenty-three years of Klebsiella phage typing: a review of phage typing of 12 clusters of nosocomial infections, and a comparison of phage typing with K serotyping. Clin.Microbiol.Infectol.6, 233–238 (2000).
83. Schuchat A.: Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin.Microbiol.Rev.11, 497–513 (1998).
84. Spellerberg B., Pohl B., Hasse G., Martin S., Weber-Heynemann J., Lutticken R.: Identification of genetic determinants for the hemolytic activity of Streptococcus agalactiae by ISS1 transposition. J.Bacteriol.181, 3212–3219 (1999a).
85. Spellerberg B., Rozdzinski B., Martin S., Weber-Heynemann J., Schnitzler N., Lutticken R., Podbielski A.: Lmb, a protein with similarities to the LraI adhesin family, mediates attachment of Streptococcus agalactiae to human laminin. Infect. Immun.67, 871–878 (1999b).
86. Spellerberg B., Martin S., Franken C., Berner R., Lutticken R.: Identification of a novel insertion sequence element in Streptococcus agalactiae. Gene241, 51–56 (2000).
87. Sriprakash K.S., Hartas J.: Genetic mosaic upstream of scpG in human group G streptococci contains sequences from group A streptococcal virulence region. Adv.Exp.Med.Biol.418, 749–751 (1997).
88. Stringer J.: The development of a phage-typing system for group-B streptococci. J.Med.Microbiol.(England)13, 133–143 (1980).
89. Suvorov A.N., Ferretti J.J.: Heterogeneity of group A pathogenic streptococci, pp. 21–24 in Pathogenic Streptococci: Present and Future (A.A. Totolian, Ed.). Lancer Publications, St. Petersburg (Russia) 1994.
90. Suvorov A., Dmitriev A., Ustinovich I., Schalen C., Totolian A.: Molecular analysis of clinical group B streptococcal strains by use of α and β gene probes. FEMS Immunol.Med.Microbiol.17, 149–154 (1997).
91. Takaisi Kukini N.B., Fehrenbach F.J.: Production and cellular compartmentation of protein B (CAMP factor) from group B streptococci, pp. 165–166 in Bacterial Protein Toxins (F.J. Fehrenbach, J.E. Alouf, P. Falmagne, W. Goebel, J. Jeljaszewicz, D. Jürgens, R. Rappuoli, Eds.). Gustav-Fischer-Verlag, Stuttgart (Germany) 1988.
92. Tamura G.S., Herndon M., Przekwas J., Rubens C.E., Ferrieri P., Hillier S.L.: Analysis of restriction fragment length polymorphisms of the insertion sequence IS1381 in group B streptococci. J.Infect.Dis.181, 364–368 (2000).
93. Tanaka D., Gyobu Y., Kodama H.: Typing of group B streptococci by pulsed-field gel electrophoresis. Kansenshogaku Zasshi69, 455–460 (1995).
94. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persins D.H., Swaminsthan B.: Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis; criteria for bacterial strain typing. J.Clin. Microbiol.33, 2233–2239 (1995).
95. Tettelin H., Masignani V., Cieslewicz M.J., Eisen J.A., Peterson S., Wessels M.R., Paulsen I.T., Nelson K.E., Margarit I., Read T.D., Madoff L.C., Wolf A.M., Beanan M.J., Brinkac L.M., Daugherty S.C., DeBoy R.T., Durkin A.S., Kolonay J.F., Madupu R., Lewis M.R., Radune D., Fedorova N.B., Scanlan D., Khouri H., Mulligan S., Carty H.A., Cline R.T., Van Aken S.E., Gill J., Scarselli M., Mora M., Iacobini E.T., Brettoni C., Galli G., Mariani M., Vegni F., Maione D., Rinaudo D., Rappuoli R., Telford J.L., Kasper D.L., Grandi G., Fraser C.M.: Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. Proc.Nat.Acad.Sci.USA99, 12391–12396 (2002).
96. Thomas-Bories I., Fitoussi F., Mariani-Kurkdjian P., Raymond J., Brahimi N., Bidet P., Lefranc V., Bingen E.: Clonal relationship between U.S. and French serotype V group B streptococcal isolates. J.Clin.Microbiol.39, 4526–4528 (2001).
97. Toresani I., Limansky A., Bogado I., Guardati M.C., Viale A., Sutich E.G.: Phenotypic and genotypic study of Streptococcus agalactiae in vagina of pregnant women in Argentina. Medicina (Buenos Aires)61, 295–300 (2001).
98. Wastfelt M., Stalhammar-Carlemalm M., Delisse A.M., Cabezon T., Lindahl G.: Identification of a family of streptococcal surface proteins with extremely repetitive structure. J.Biol.Chem.271, 18892–18897 (1996).
99. Whiley R.A., Hall L.M.C., Hardie J.M., Beighton D.: Intraspecific diversity within Streptococcus anginosus. Adv.Exp.Med.Biol.418, 367–369 (1997).
100. Wibavan I.W., Lammler C., Smola J.: Properties and type antigen patterns of group B streptococcal isolates from pigs and nutrias. J.Clin.Microbiol.31, 762–764 (1993).